Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage.
A breakthrough external beam radiotherapy technology that is fast and has optimal dose delivery to targeted tumors is the latest radiotherapy weapon that specialists are using at Stony Brook University Medical Center.
Arthur Stone, Ph.D., Distinguished Professor and Vice Chairman of Psychiatry & Behavioral Science at Stony Brook University and colleagues have produced an analysis of how Americans perceive well-being at various ages.
A new state-of-the art computed tomography (CT) scanner that provides physicians with precise images of internal organs with a single rotation of the gantry is now in operation at Stony Brook University Medical Center.
Research conducted at the Stony Brook University that enhances the time a drug remains bound to its target, or residence time, may prove to be an important step in developing better diagnostic and therapeutic agents.
On April 27, Stony Brook University Cancer Center and the Department of Molecular Genetics & Microbiology at Stony Brook University will hold a one-day symposium titled “Cancer Stem Cells, Differentiation, and Metastasis.”
The Department of Orthopaedics at Stony Brook University Medical Center Orthopaedists and 19 other hand surgery specialists from around the world will lecture at the Dupuytren’s Disease Symposium on April 17.
A new study led by a Stony Brook University researcher tests the effectiveness of providing follow-up support to patients for managing pain by way of an automated system that patients use via their home telephone.
A new edition of Cardiac Intensive Care, the only textbook dedicated to cardiac intensive care medicine, chronicles the progress made in the diagnosis and treatment of patients with critical cardiac illness.
A new procedure for treating pancreatic and liver cancers using electrical fields to poke holes in tumors was used for the first time anywhere to fight pancreatic cancer at Stony Brook University Medical Center.
A life-sized reconstruction of the “devil frog,” the largest frog known to ever exist; a cast of the complete skeleton of a small meat-eating dinosaur named after Mark Knopfler, the lead singer from the rock band Dire Straits; a skeleton and life-sized reconstruction of a rare, 2.5 foot long pug-nosed vegetarian crocodile; and a pristinely preserved skull of a large dinosaur predator still partially entombed in sandstone are among the 65 million year old fossils from Madagascar that were publicly unveiled for the first time at Stony Brook University on Tuesday, February 9, 2010.
The U.S. Food and Drug Administration (FDA) has approved Xiaflex, a new drug to treat Dupuytren’s contracture (or disease) that was discovered and developed by Marie A. Badalamente, Ph.D., and Lawrence C. Hurst, M.D., in the Department of Orthopaedics at Stony Brook University Medical Center.
Shark pups born to virgin mothers can survive over the long-term, according to new research published Jan. 25 in the Journal of Heredity. The study shows for the first time that some virgin births can result in viable offspring.
A newly discovered dinosaur that lived approximately 215 million years ago (Triassic Period) in the region of New Mexico in the United States is providing a team of paleontologists new information on early dinosaur evolution.
A study of 2,203 cardiac surgery patients from Veterans Affairs (VA) medical centers nationwide revealed that coronary-artery bypass grafting (CABG) completed “off-pump,” meaning without a heart-lung machine, had no advantages in patient outcomes compared to the traditional “on-pump” procedure.
A scientific analysis of a recently discovered adapiform, an ancient primate, reveals that the fossil, called Afradapis, is not on the evolutionary lineage of anthropoids (Old World Monkeys and higher primates, including humans) but instead more closely to lemurs and lorises.
A one-day free conference dedicated to educating teachers, nurses, social workers, guidance counselors, and other educators about the medical and educational issues that children with cancer encounter when returning to school, will take place on November 3, 2009, at the Wang Center at Stony Brook University.
The Lenfest Forage Fish Task Force will meet from October 12-14 in Portland, ME to continue developing critical management recommendations for small prey fish like sardines, anchovies and menhaden that are caught by commercial fisheries on a massive scale, almost always without consideration of their essential role in oceanic food webs.
Minimizing diagnostic error in medicine is an essential component of safe patient care, a theme to be explored by the physicians, medical scientists, safety officers, and risk managers who will convene at the 2nd Annual Diagnostic Error in Medicine Conference, to be held at the Renaissance Hollywood Hotel on October 21-22 in Los Angeles.
The School of Social Welfare at Stony Brook University is sponsoring an innovative Geriatric Care Ministry Program that is designed to help clergy of all faiths and other spiritual leaders improve the quality-of-life for older people in their congregations and communities.
The Center for Biotechnology at Stony Brook University has organized an unprecedented summit that will bring some of the world’s top bioscience companies with innovative scientists, entrepreneurs, and some of the nation’s leading universities to explore the next generation of biomedical solutions that may lead to groundbreaking discoveries.
Researchers in the Department of Orthopaedics at Stony Brook University Medical Center have developed an injectable form of the enzyme, collagenase, that significantly improves outcomes of Dupuytren’s contracture (or disease), a debilitating disorder caused by progressive accumulation of collagen that deforms fingers and limits motion.
A study led by Stony Brook University Medical Center finds that preschool age children from socioeconomically disadvantaged families are less likely to have consistent bedtime routines than their more advantaged counterparts. The authors say this pattern may contribute to later disparities in sleep quality and possibly health.
The signing today of a comprehensive green “Memorandum of Understanding” (MOU) between Stony Brook University Hospital and the United States Environmental Protection Agency (EPA) marks a first for any hospital in the United States.
AstraZeneca, Pfizer and other top bioscience companies will come together with some of the nation's leading universities to lead the development of the Life Sciences Summit 2009"“ Showcasing Innovation, Promoting Collaboration. The Center for Biotechnology at Stony Brook University is the organizer of the Summit, which will take pace on September 23-24, 2009 on Long Island, N.Y.
Cancer patients treated with the widely used drug bevacizumab (Avastin) in combination with chemotherapy are at greater risk of life-thereatening gastrointestinal (GI) perforations. This is the conclusion of Shenhong Wu, M.D., Ph.D., and colleagues at Stony Brook University Medical Center, in a study published online and in the June print issue of The Lancet Oncology.
An international team of paleoanthropologists, anatomists and archeologists, led by William L. Jungers, Ph.D., of Stony Brook University,have published the first scientific analysis of the foot of Homo floresiensis, the fossil found in Indonesia in 2003 and popularly referred to as the "Hobbit." Their findings are reported in the May 7 issue of Nature.
A group of 12 proteins associated with pediatric multiple sclerosis (MS) have been discovered for the first time by a team of neurology and pathology researchers at Stony Brook University Medical Center. Led by Lauren Krupp, M.D., Director of the National Pediatric MS Center at SBUMC, the finding could lead to a new panel of diagnostic and prognostic markers in pediatric MS.
The second annual Meeting of the Minds symposium brings together leaders in the field of cardiovascular medicine to discuss and debate issues through the prism of quantifiable outcomes and evidence-based medicine. Focusing on the latest clinical research, speakers will raise critical questions that provoke serious thought "“ all with the goal of improving patient care.
Stony Brook University researchers discovered a new molecular mechanism for the processing of endocannabinoids, brain compounds similar to THC, the active ingredient in marijuana, and essential in physiological processes such as pain, appetite, and memory. The finding could pave the way for new medicines for pain, addiction, appetite control and other disorders.
A new form of ultrasound that assesses multiple parameters of hard tissue like bone may lead to early prediction of bone loss, a hallmark of osteoporosis, a disease affecting millions of Americans.
On June 4 and 5, 2009, Stony Brook University Medical Center specialists in cardiovascular medicine will hold the "Meeting of the Minds" Symposium, where leaders in the field discuss and debate issues on the latest advances in therapy for cardiovascular disease.
Excessive discussion of problems between adolescent friends may lead to depression and anxiety, according to research published in the February issue of the Journal of Adolescence.
In a an analysis of the size, shape and asymmetry of the cranium of Homo floresiensis, Karen Baab, Ph.D., a researcher in the Department of Anatomical Sciences at Stony Brook University, and colleagues conclude that the fossil, found in Indonesia in 2003 and known as the "Hobbit," is not human.
The December 2008 issue of Discover magazine included in its top 100 science stories of the year studies that back the "new species" theory of the 18,000-year-old hominid found on the Indonesian island of Flores in 2004. The discovery of Homo floresiensis, nicknamed the "the hobbit," remains controversial and could lead to rewriting the story of human evolution.
Country music singer Clay Walker's non-profit charity, Band Against MS (BAMS), donated $100,000 to the National Pediatric MS (Multiple Sclerosis) Center at Stony Brook University Medical Center.
The Department of Biomedical Engineering at Stony Brook University received a $1.8 million grant from the National Institutes of Health (NIH) to investigate the biologic and physical mechanisms of very low-magnitude mechanical signals and how they strengthen bone and muscle.
Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, received a $4 million grant from the National Institute of Mental Health (NIMH) to launch a study to compare treatment options for children with Attention Deficit Hyperactivity Disorder (ADHD) and severe behavioral problems.
Researchers at Stony Brook University's (SBU) School of Dental Medicine and School of Medicine received a $12.5 million five-year grant from the National Institute of Dental and Craniofacial Research (NIDCR), an arm of the National Institutes of Health, to conduct a multi-center clinical trial to evaluate whether treatment of chronic periodontitis may help to improve diabetes control.
The lead product from a new class of agents called Altered Energy Metabolism Directed (AEMD) compounds developed by Cornerstone Pharmaceuticals, Inc., from technology licensed from The Research Foundation of SUNY, on behalf of Stony Brook University, has been approved by the U.S. Food and Drug Administration for evaluation in Phase I/II clinical trials to treat cancer.
Stony Brook University Medical Center's Long Island World Trade Center Medical Monitoring and Treatment Program was awarded $9 million from the National Institute for Occupational Safety and Health (NIOSH) for its medical programs over the next year. The program has cared for thousands of 9/11 first responders, many of whom continue to suffer from health issues related to their work at ground zero.
A study led by Roy T. Steigbigel, M.D., of Stony Brook University Medical Center, and colleagues worldwide demonstrated that raltegravir, a new medication to treat HIV infection, combined with other anti-HIV medications, provided superior suppression of HIV-1 in patients with highly resistant virus compared to placebo used with other anti-HIV medications.
This CME conference covers state-of-the-art practices in diagnosing and treating Inflammatory Bowel Disease (IBD). Featured presentations and discussions include: immunomodulators versus biologic treatment, what is new in IBD radiology, innovative surgical techniques to treat disease, and special needs of the pediatric population.
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and colleagues discovered that a certain clone of Borrelia burgdorferi, the spirochete that causes Lyme disease, appears to be the most common strain causing Lyme disease in North America and Europe, and may account for the increase in cases for the past 20 years.
A team of molecular biologists and computer scientists at Stony Brook University has designed and synthesized a new class of weakened polioviruses. They used their synthesizing method with computer software to systematically re-code the poliovirus genome. In doing so, the team is the first to demonstrate that a synthetic weakened virus can immunize an animal.
Researchers from Stony Brook University Medical Center have found that women in the United States who have urinary cadmium levels that are below the U.S. Occupational Safety & Health Administration safety standard are at risk for osteoporosis.
Many patients with Crohn's disease, a chronic condition that involves relapsing inflammation of the gastrointestinal tract, develop advancing disease and no longer respond to therapy. To help patients refractory to treatment, Stony Brook University Medical Center is conducting a clinical trial that infuses cells derived from adult bone marrow into patients to induce disease remission.
On Wednesday, June 11, at 9:00 am, Harry (Hal) C. Dietz, M.D., Victor A. McKusick Professor of Genetics and Medicine, Johns Hopkins University School of Medicine, will discuss his groundbreaking work regarding the pathogenesis and treatment of Marfan syndrome at Stony Brook University Medical Center.
David G. Thanassi, Ph.D., of Stony Brook University, and colleagues are the first to capture a view of proteins during translocation across the bacterial outer membrane. This "molecular snapshot" may enlighten scientists to the protein secretion process across membranes and provide a foundation to understanding certain bacterial virulence factors that allow bacteria to cause disease.
Based on a random survey of nearly 4,000 U. S. respondents, Arthur A. Stone, Ph.D., Distinguished Professor and Vice Chair, Department of Psychiatry and Behavioral Science at Stony Brook University, and Alan Krueger, Ph.D., Professor, Department of Economics and the Woodrow Wilson School at Princeton University, report than more than 25 percent of American men and women experience daily pain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right